How often should I get scans to monitor my Glioblastoma

Scan Monitoring for Glioblastoma

This is an important question, and the honest answer is: there's no one-size-fits-all schedule — it depends on your specific situation, treatment plan, and your oncologist's assessment. Let me explain how doctors typically approach this.

How Doctors Think About Monitoring

Your care team considers several factors when deciding on scan frequency:

• Your treatment phase (newly diagnosed vs. recurrent disease)
• What treatment you're receiving (surgery, radiation, chemotherapy, immunotherapy, or combinations)
• How your tumor is responding to treatment
• Your overall health and symptoms
• Whether you're in a clinical trial (which may have specific monitoring protocols)

General Monitoring Approaches

During active treatment: Most patients receive MRI scans every 4-8 weeks to assess how the tumor is responding. This helps your doctor determine if the current treatment is working or if adjustments are needed.

After initial treatment completion: Scans typically become less frequent — often every 2-3 months initially, then potentially extending to every 3-6 months if you remain stable.

Long-term follow-up: Some patients eventually transition to scans every 6-12 months if they've had sustained stability.

Important Considerations

The webinar on personalized T-cell immunotherapy for glioblastoma mentions that treatment approaches are increasingly individualized. If you're considering or enrolled in a clinical trial, that trial will have its own specific imaging schedule — sometimes more frequent than standard care to carefully monitor immune response.

Additionally, symptom-driven monitoring is important. If you develop new neurological symptoms (headaches, vision changes, weakness, speech difficulties), your doctor may order scans sooner than the regular schedule, regardless of when the next one was planned.

Questions to Ask Your Oncologist

1. What is my specific scan schedule, and why? (Ask for a written timeline)
2. What are we looking for on these scans? (Tumor size, new areas of concern, treatment response)
3. Will the schedule change based on my response to treatment?
4. If I develop new symptoms, should I contact you before the next scheduled scan?
5. Are there any clinical trials I should consider that might offer different monitoring or treatment approaches?

According to NCCN Guidelines for Central Nervous System Cancers, imaging surveillance is individualized based on treatment response and clinical status, though specific intervals aren't rigidly defined in guidelines — this is why your doctor's judgment about YOUR case is so important.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.